Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 22, 2025 • 5:00 AM ET

Date/Time Source News Release
12/03/2024 07:00 AM EST GlobeNewswire Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit
11/19/2024 07:00 AM EST GlobeNewswire Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab's CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis
11/14/2024 07:00 AM EST GlobeNewswire Chemomab Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
10/30/2024 07:00 AM EDT GlobeNewswire Chemomab Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update
10/15/2024 07:00 AM EDT GlobeNewswire Chemomab Therapeutics Announces Late-Breaking Oral Presentation of CM-101 Phase 2 Results in Primary Sclerosing Cholangitis at AASLD The Liver Meeting® 2024
10/01/2024 07:00 AM EDT GlobeNewswire Chemomab Therapeutics to Present at October 2024 Investor Conferences
08/28/2024 07:00 AM EDT GlobeNewswire Chemomab Therapeutics to Present at September 2024 Investor Conferences
08/21/2024 07:00 AM EDT GlobeNewswire Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
08/12/2024 07:00 AM EDT GlobeNewswire Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update
07/30/2024 09:00 AM EDT GlobeNewswire Chemomab Therapeutics Announces Closing of $10 Million Private Placement
Page

Additional News

As of January 22, 2025 • 5:00 AM ET

Date/Time Source News Release
11/14/2024 10:00 AM EST SeekingAlpha Chemomab Therapeutics GAAP EPS of -$0.01 beats by $0.05
11/14/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, November 14th, 2024
11/14/2024 04:37 AM EST US Earnings Reports Expected earnings - Chemomab Therapeutics Ltd.
08/21/2024 07:06 AM EDT SeekingAlpha Chemomab Therapeutics GAAP EPS of -$0.01
08/21/2024 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, August 21st, 2024
08/21/2024 05:38 AM EDT US Earnings Reports Expected earnings - Chemomab Therapeutics Ltd.
08/12/2024 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, August 12th, 2024
08/12/2024 05:40 AM EDT US Earnings Reports Expected earnings - Chemomab Therapeutics Ltd.
07/26/2024 07:04 AM EDT SeekingAlpha Chemomab Therapeutics regains compliance with Nasdaq
07/25/2024 01:36 PM EDT SeekingAlpha Chemomab falls on private placement despite mid-stage win for lead asset
Page